Prevalence of contraindications and prescription of pharmacologic therapies for gout: Commentary

Tom Huizinga^*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	65-66
Number of pages	2
Journal	International Journal of Advances in Rheumatology
Volume	9
Issue number	2
State	Published - Dec 1 2011

ASJC Scopus subject areas

@article{77eb2bb0800a4b68bcd01e2ee9cea5f5,

title = "Prevalence of contraindications and prescription of pharmacologic therapies for gout: Commentary",

author = "Tom Huizinga and Peter Nigrovic and Eric Ruderman and Hendrik Schulze-Koops",

year = "2011",

month = dec,

day = "1",

language = "English (US)",

volume = "9",

pages = "65--66",

journal = "International Journal of Advances in Rheumatology",

issn = "1478-856X",

publisher = "Remedica Medical Education and Publishing Ltd",

number = "2",

}

TY - JOUR

T1 - Prevalence of contraindications and prescription of pharmacologic therapies for gout

T2 - Commentary

AU - Huizinga, Tom

AU - Nigrovic, Peter

AU - Ruderman, Eric

AU - Schulze-Koops, Hendrik

PY - 2011/12/1

Y1 - 2011/12/1

UR - http://www.scopus.com/inward/record.url?scp=84863836742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863836742&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:84863836742

SN - 1478-856X

VL - 9

SP - 65

EP - 66

JO - International Journal of Advances in Rheumatology

JF - International Journal of Advances in Rheumatology

IS - 2

ER -